Full-paper Knowledge Units · saved output

A six-month periodic fasting reduces microalbuminuria and improves metabolic control in patients with type 2 diabetes and diabetic nephropathy: a randomized controlled study

Gemma 4 E4B IT · KU LoRA rank 128 · 1,000-word source chunks · guarded TranslateGemma 4B back-translation

Complete extractionLongest literal run: 11 words

Source title: A six-month periodic fasting reduces microalbuminuria and improves metabolic control in patients with type 2 diabetes and diabetic nephropathy: a randomized controlled study
Source authors: Alba Sulaj; Stefan Kopf; Ekaterina Von Rauchhaupt; Elisabeth Kliemank; Maik Brune; Zoltan Kender; Hannelore Bartl; Fabiola Garcia Cortizo; Katarina Klepac; Zhe Han; Varun Kumar; Valter Longo; Aurelio Teleman; Jürgen G Okun; Jakob Morgenstern; Thomas Fleming; Julia Szendroedi; Stephan Herzig; Peter P Nawroth
KU document title: A six-month periodic fasting reduces microalbuminuria and improves metabolic control in patients with type 2 diabetes and diabetic nephropathy: a randomized controlled study
KU document author field: Not populated by the original extractor
Style annotation: No dedicated document-style field in this schema
KU sequence: 5 of 5 expected chunks
Attribution provenance: Source registry metadata shown for attribution; not added to the QA context

This condition scores 78.0% (156/200) across all 20 evaluation papers. The example page does not imply that every claim in this individual paper is correct.

Gemma 4 12B IT · KU LoRA rank 128 · 500 words Gemma 4 12B IT · KU LoRA rank 128 · 1,000 words Gemma 4 E4B IT · KU LoRA rank 128 · 500 words Gemma 4 E4B IT · KU LoRA rank 128 · 1,000 words Qwen 3.8 27B FP8 · teacher · 500 words Qwen 3.8 27B FP8 · teacher · 1,000 words

Every saved KU, entity, attribute and relationship is shown below, in original chunk order. Navigation follows the source sequence rather than publication dates. Adjacent summaries are reader navigation, not lookahead supplied to extraction. All KUs were generated before the paraphrasing stage. Download complete factual KU JSON.

Jump to KU: 1 2 3 4 5

KU 1 · source words 1–995

14 entities · 23 relationships · 0 preceding KUs available during extraction

Recorded context summary

A randomized controlled study assessed the effects of a six-month fasting-mimicking diet versus a Mediterranean diet on patients with type 2 diabetes and diabetic nephropathy. The study found that the fasting-mimicking diet reduced microalbuminuria and HOMA-IR, but not macroalbuminuria, with effects sustained only at the three-month follow-up. The researchers suggest that the lack of change in dicarbonyl detoxification and DNA-damage markers may explain the relapse of albuminuria.

six-month periodic fasting

method · ID: six_month_periodic_fasting

duration: six months
diet_type: fasting-mimicking diet (FMD)

Relationships

reduces → microalbuminuria
improves → metabolic control
reduces → HOMA-IR
reduces → suPAR

fasting-mimicking diet (FMD)

method · ID: fasting_mimicking_diet_fmd

n_patients: 21
duration: six months

Relationships

compared_to → Mediterranean diet
reduces → microalbuminuria
reduces → HOMA-IR

Mediterranean diet

method · ID: mediterranean_diet

n_patients: 19
duration: six months

Relationships

compared_to → fasting-mimicking diet (FMD)

microalbuminuria

measurement · ID: microalbuminuria

definition: increased albumin-to-creatinine ratio (ACR)

Relationships

reduced_by → fasting-mimicking diet (FMD)
reduced_by → fasting-mimicking diet (FMD)

macroalbuminuria

measurement · ID: macroalbuminuria

definition: increased albumin-to-creatinine ratio (ACR)

Relationships

not_reduced_by → fasting-mimicking diet (FMD)

HOMA-IR

measurement · ID: homa_ir

change_after_six_months: -3.8
change_at_follow_up: -1.9

Relationships

reduced_by → fasting-mimicking diet (FMD)
sustained_reduction_at → three-month follow-up

suPAR

measurement · ID: supar

change_after_six_months: -156.6 pg/ml

Relationships

reduced_by → fasting-mimicking diet (FMD)

dicarbonyl detoxification markers

measurement · ID: dicarbonyl_detoxification_markers

examples: MG-H1, glyoxalase-1, hydroxyacetone

Relationships

no_change_observed_with → fasting-mimicking diet (FMD)

DNA-damage/repair markers

measurement · ID: dna_damage_repair_markers

example: yH2Ax

Relationships

no_change_observed_with → fasting-mimicking diet (FMD)

senescence markers

measurement · ID: senescence_markers

example: suPAR

Relationships

reduced_by → fasting-mimicking diet (FMD)

type 2 diabetes

other · ID: type_2_diabetes

baseline_HbA1c: 7.8±0.2%
baseline_mmol/mol: 62.1±2.3
model_entity_type: condition

Relationships

treated_with → fasting-mimicking diet (FMD)
treated_with → Mediterranean diet

diabetic nephropathy

other · ID: diabetic_nephropathy

definition: increased albumin-to-creatinine ratio (ACR)
model_entity_type: condition

Relationships

treated_with → fasting-mimicking diet (FMD)
treated_with → Mediterranean diet

Heidelberg University Hospital

organization · ID: heidelberg_university_hospital

department: Clinics of Endocrinology, Diabetology, Metabolism and Clinical Chemistry

Relationships

conducted → randomized controlled study

German Clinical Trials Register (DRKS)

organization · ID: german_clinical_trials_register_drks

id: DRKS00014287

Relationships

registered → randomized controlled study

Source positions, MinHash and extraction warnings

{
  "source": {
    "chunk_index": 0,
    "start_word": 0,
    "end_word": 995,
    "word_count": 995,
    "sha256": "774d4d1f3bd8c4b93cef6c482e941d8ff21d509d4580a2017016ad70414abe37",
    "sentence_minhash": [
      6510041791773535,
      7605519510423274,
      12309405932600981,
      61919449716151556,
      31941388625203915,
      62667647458868521,
      23718652799488495,
      83575544965282909,
      130591936822558120,
      2607707833378508,
      6226213327830117,
      95656761971753031,
      21933493368060407,
      906306679132868,
      73860429008392155,
      658790404649858
    ]
  },
  "extraction_warnings": [
    "normalized unsupported entity type 'condition' for 'type 2 diabetes'",
    "normalized unsupported entity type 'condition' for 'diabetic nephropathy'"
  ]
}

Previous KU: Start of paper

Next KU: The study randomized 38 patients with type 2 diabetes and diabetic nephropathy into a fasting-mimicking diet or Mediterranean diet group. The FMD involved specific caloric and macronutrient compositions for five consecutive days each month, while the M-Diet maintained caloric intake. Primary and secondary endpoints included changes in ACR, HOMA-IR, and various metabolic markers, with statistical analysis performed using ANCOVA on the intention-to-treat population.

KU 2 · source words 996–1,975

17 entities · 22 relationships · 1 preceding KUs available during extraction

Recorded context summary

The study randomized 38 patients with type 2 diabetes and diabetic nephropathy into a fasting-mimicking diet or Mediterranean diet group. The FMD involved specific caloric and macronutrient compositions for five consecutive days each month, while the M-Diet maintained caloric intake. Primary and secondary endpoints included changes in ACR, HOMA-IR, and various metabolic markers, with statistical analysis performed using ANCOVA on the intention-to-treat population.

six-month periodic fasting

method · ID: six_month_periodic_fasting

duration: six months
frequency: five consecutive days each month
diet_type: plant-based
caloric_intake_day_1: 4600 kJ
macronutrients_day_1: 11% protein, 46% fat, 43% carbohydrates
caloric_intake_days_2_to_5: 3000 kJ
macronutrients_days_2_to_5: 9% protein, 44% fat, 47% carbohydrate

Relationships

mimics → fasting-like effects on glucose and ketone bodies
used_in_study → randomized controlled study

Mediterranean diet

method · ID: mediterranean_diet

caloric_intake: no change compared to pre-study diet
adaptation_method: Mediterranean Diet Score (MDS)

Relationships

used_in_study → randomized controlled study

randomized controlled study

event · ID: randomized_controlled_study

duration: six months
sample_size_calculated: 40
sample_size_actual: 38
dropout_rate_actual: 15.8%
follow_up_time: 112±31 days

Relationships

randomized_participants_by → BMI and HbA1c
used_randomizer → Randomizer Version 2.0.3
primary_endpoint → absolute difference of change of ACR
secondary_endpoints → HOMA-IR, plasma MG-H1, plasma MG, Glo-1 activity, pGlo-1 expression, hydroxyacetone, plasma AC profile, yH2Ax expression, suPAR

ACR

measurement · ID: acr

unit: absolute difference of change
measurement_frequency: baseline, three diet cycles, six diet cycles

Relationships

primary_endpoint_of → randomized controlled study
subgroup_analysis_performed_for → micro-versus macroalbuminuria levels at baseline

HOMA-IR

measurement · ID: homa_ir

unit: absolute difference of change
measurement_frequency: three diet cycles, six diet cycles

Relationships

secondary_endpoint_of → randomized controlled study

plasma MG-H1

measurement · ID: plasma_mg_h1

unit: absolute difference of change
measurement_frequency: three diet cycles, six diet cycles

Relationships

secondary_endpoint_of → randomized controlled study

plasma MG

measurement · ID: plasma_mg

unit: absolute difference of change
measurement_frequency: three diet cycles, six diet cycles

Relationships

secondary_endpoint_of → randomized controlled study

Glo-1 activity

measurement · ID: glo_1_activity

unit: absolute difference of change
measurement_frequency: three diet cycles, six diet cycles

Relationships

secondary_endpoint_of → randomized controlled study

pGlo-1 expression

measurement · ID: pglo_1_expression

unit: absolute difference of change
measurement_frequency: three diet cycles, six diet cycles

Relationships

secondary_endpoint_of → randomized controlled study

hydroxyacetone

measurement · ID: hydroxyacetone

unit: absolute difference of change
measurement_frequency: three diet cycles, six diet cycles

Relationships

secondary_endpoint_of → randomized controlled study

plasma AC profile

measurement · ID: plasma_ac_profile

unit: absolute difference of change
measurement_frequency: three diet cycles, six diet cycles

Relationships

secondary_endpoint_of → randomized controlled study

yH2Ax expression

measurement · ID: yh2ax_expression

unit: absolute difference of change
measurement_frequency: three diet cycles, six diet cycles

Relationships

secondary_endpoint_of → randomized controlled study

suPAR

measurement · ID: supar

unit: absolute difference of change
measurement_frequency: three diet cycles, six diet cycles

Relationships

secondary_endpoint_of → randomized controlled study

ANCOVA

method · ID: ancova

adjustment_variables: age, sex, weight loss, baseline value of outcome

Relationships

used_for → comparison of changes between FMD and M-Diet group

intention-to-treat population

concept · ID: intention_to_treat_population

definition: at least baseline and three and/or sixth months data available
missing_value_handling: not imputed

Relationships

used_for → statistical analysis

PASS 16.0.12

method · ID: pass_16_0_12

purpose: sample size calculation

Relationships

used_for → sample size calculation

GraphPad Prism version 5.00

other · ID: graphpad_prism_version_5_00

developer: GraphPad Software
location: San Diego California USA
model_entity_type: software

Relationships

used_for → data visualization

Source positions, MinHash and extraction warnings

{
  "source": {
    "chunk_index": 1,
    "start_word": 995,
    "end_word": 1975,
    "word_count": 980,
    "sha256": "fb3400d72cb091e8e4496d43483baa8fbffcf160f6a9c4938c617dfebaae5dc8",
    "sentence_minhash": [
      78394354238995921,
      18551641988871988,
      13745959893517690,
      61919449716151556,
      31941388625203915,
      62667647458868521,
      22742697865333914,
      40361113771795953,
      64333332902950267,
      9462436175016187,
      10770288728711951,
      95656761971753031,
      38129318889309710,
      906306679132868,
      29116561381011342,
      3126852891561233
    ]
  },
  "extraction_warnings": [
    "normalized unsupported entity type 'software' for 'GraphPad Prism version 5.00'"
  ]
}

Previous KU: A randomized controlled study assessed the effects of a six-month fasting-mimicking diet versus a Mediterranean diet on patients with type 2 diabetes and diabetic nephropathy. The study found that the fasting-mimicking diet reduced microalbuminuria and HOMA-IR, but not macroalbuminuria, with effects sustained only at the three-month follow-up. The researchers suggest that the lack of change in dicarbonyl detoxification and DNA-damage markers may explain the relapse of albuminuria.

Next KU: The study found that the fasting-mimicking diet reduced microalbuminuria and HOMA-IR, but not macroalbuminuria, with effects sustained only at the three-month follow-up. The researchers suggest that the lack of change in dicarbonyl detoxification and DNA-damage markers may explain the relapse of albuminuria.

KU 3 · source words 1,976–2,958

16 entities · 27 relationships · 2 preceding KUs available during extraction

Recorded context summary

The study found that the fasting-mimicking diet reduced microalbuminuria and HOMA-IR, but not macroalbuminuria, with effects sustained only at the three-month follow-up. The researchers suggest that the lack of change in dicarbonyl detoxification and DNA-damage markers may explain the relapse of albuminuria.

six-month periodic fasting

method · ID: six_month_periodic_fasting

duration: six months
frequency: periodic
diet_cycles: six

Relationships

reduces → microalbuminuria
improves → metabolic control
sustains_effects_at → three-month follow-up

fasting-mimicking diet (FMD)

method · ID: fasting_mimicking_diet_fmd

diet_cycles: six
caloric_composition: Specific calorie and macronutrient compositions for five consecutive days per month

Relationships

reduces → microalbuminuria
reduces → HOMA-IR
reduces → urea levels
after_three_cycles
11.8 mg/dl
after_six_cycles
17.9 mg/dl
reduces → eGFR decline
after_six_cycles
8.3 ml/min/1.73m²
reduces → suPAR
after_three_cycles
214.8 pg/ml
after_six_cycles
156.6 pg/ml
reduces → HbA1c
after_six_cycles
1.1%
causes → weight loss
after_three_cycles
5.6 kg
after_six_cycles
7.2 kg
causes → adverse_effects
incidence
71 to 95%
severity
grade 1 or grade 2
symptoms
weakness, muscle pain, dizziness, headache

Mediterranean diet

method · ID: mediterranean_diet

caloric_intake: maintained

Relationships

compared_to → fasting-mimicking diet (FMD)

microalbuminuria

measurement · ID: microalbuminuria

reduction_after_six_cycles: 54%
reduction_after_three_cycles: 37%

Relationships

affected_by → fasting-mimicking diet (FMD)

macroalbuminuria

measurement · ID: macroalbuminuria

reduction_after_six_cycles: 434.0 mg/g
reduction_after_three_cycles: 176.2 mg/g

Relationships

affected_by → fasting-mimicking diet (FMD)

HOMA-IR

measurement · ID: homa_ir

reduction_after_six_cycles: 60%
reduction_after_three_cycles: not_specified

Relationships

affected_by → fasting-mimicking diet (FMD)

eGFR based on cystatin C

measurement · ID: egfr_based_on_cystatin_c

difference_after_six_cycles: 8.3 ml/min/1.73m²
difference_after_three_cycles: 2.4 ml/min/1.73m²

Relationships

affected_by → fasting-mimicking diet (FMD)

suPAR

measurement · ID: supar

difference_after_three_cycles: 214.8 pg/ml
difference_after_six_cycles: 156.6 pg/ml

Relationships

affected_by → fasting-mimicking diet (FMD)

HbA1c

measurement · ID: hba1c

reduction_after_six_cycles: 1.1%

Relationships

affected_by → fasting-mimicking diet (FMD)

fasting plasma glucose (FPG)

measurement · ID: fasting_plasma_glucose_fpg

change_after_six_cycles: comparable between groups

Relationships

affected_by → fasting-mimicking diet (FMD)

HOMA-IR in non-insulin treated participants

measurement · ID: homa_ir_in_non_insulin_treated_participants

reduction_after_six_cycles: 60%

Relationships

affected_by → fasting-mimicking diet (FMD)

LDL, HDL, triglyceride levels

measurement · ID: ldl_hdl_triglyceride_levels

change_after_six_cycles: There was no change in the group with FMD compared to the group on the M-diet, or compared to the initial value.

Relationships

affected_by → fasting-mimicking diet (FMD)

plasma MG-H1

measurement · ID: plasma_mg_h1

reduction_after_three_cycles: 62%

Relationships

affected_by → fasting-mimicking diet (FMD)

acetylcarnitine levels (C2)

measurement · ID: acetylcarnitine_levels_c2

increase_after_three_cycles: in responders

Relationships

associated_with → responders

responders

concept · ID: responders

definition: participants with at least 30% improvement in ACR

Relationships

have_lower_baseline_ACR → fasting-mimicking diet (FMD)
value
85.7 mg/g
have_lower_baseline_ACR → Mediterranean diet
value
55.5 mg/g

non-responders

concept · ID: non_responders

definition: participants without at least 30% improvement in ACR

Relationships

have_higher_baseline_ACR → fasting-mimicking diet (FMD)
value
271 mg/g
have_higher_baseline_ACR → Mediterranean diet
value
563.0 mg/g

Source positions, MinHash and extraction warnings

{
  "source": {
    "chunk_index": 2,
    "start_word": 1975,
    "end_word": 2958,
    "word_count": 983,
    "sha256": "87b01caf118dbbec19a066af33c8354f121c997f8ce6ad6d776f9261a7323b00",
    "sentence_minhash": [
      6919897742352966,
      60625189416255572,
      40863640610520970,
      10004148275772588,
      31941388625203915,
      39127440086368283,
      89633613770379075,
      85390325476433150,
      34383880606747972,
      2607707833378508,
      104535835787444099,
      95656761971753031,
      38129318889309710,
      906306679132868,
      95169533629451962,
      109206766937244242
    ]
  },
  "extraction_warnings": []
}

Previous KU: The study randomized 38 patients with type 2 diabetes and diabetic nephropathy into a fasting-mimicking diet or Mediterranean diet group. The FMD involved specific caloric and macronutrient compositions for five consecutive days each month, while the M-Diet maintained caloric intake. Primary and secondary endpoints included changes in ACR, HOMA-IR, and various metabolic markers, with statistical analysis performed using ANCOVA on the intention-to-treat population.

Next KU: The study found that the fasting-mimicking diet reduced microalbuminuria and improved metabolic control in type 2 diabetes patients, but these effects were transient and did not alter macroalbuminuria. The diet led to a reduction in antihyperglycemic and antihypertensive medication use, and increased blood ketones, while maintaining comparable glycemic and blood pressure control to the Mediterranean diet group. The researchers attribute the transient nature of the albuminuria reduction to the lack of sustained changes in dicarbonyl detoxification and DNA-damage repair markers.

KU 4 · source words 2,959–3,938

12 entities · 13 relationships · 3 preceding KUs available during extraction

Recorded context summary

The study found that the fasting-mimicking diet reduced microalbuminuria and improved metabolic control in type 2 diabetes patients, but these effects were transient and did not alter macroalbuminuria. The diet led to a reduction in antihyperglycemic and antihypertensive medication use, and increased blood ketones, while maintaining comparable glycemic and blood pressure control to the Mediterranean diet group. The researchers attribute the transient nature of the albuminuria reduction to the lack of sustained changes in dicarbonyl detoxification and DNA-damage repair markers.

fasting-mimicking diet (FMD)

method · ID: fasting_mimicking_diet_fmd

duration: six-month periodic
effect_on_microalbuminuria: reduction
effect_on_macroalbuminuria: no change
effect_on_HOMA-IR: sustained improvement
effect_on_blood_ketones: 3-fold increase after three and six diet cycles
effect_on_antihyperglycemic_medication: reduction in 57% of participants after three cycles, 67% after six cycles
effect_on_antihypertensive_medication: reduction in 10% of participants after three cycles, 10% after six cycles
effect_on_dicarbonyl_detoxification: transient reduction of MG-H1
effect_on_DNA_damage_repair: no change
effect_on_suPAR: fast increase after FMD

Relationships

compared_to → Mediterranean diet

Mediterranean diet

method · ID: mediterranean_diet

effect_on_microalbuminuria: no change
effect_on_macroalbuminuria: no change
effect_on_HOMA-IR: no sustained improvement
effect_on_blood_ketones: no significant increase
effect_on_antihyperglycemic_medication: reduction in 32% of participants after three cycles, 21% after six cycles
effect_on_antihypertensive_medication: reduction in 5% of participants after three cycles, 10% after six cycles
effect_on_dicarbonyl_detoxification: no change
effect_on_DNA_damage_repair: no change

Relationships

compared_to → fasting-mimicking diet (FMD)

microalbuminuria

measurement · ID: microalbuminuria

reduction_in_FMD: observed
reduction_in_M-Diet: not observed
reduction_in_overall_group: not observed

Relationships

affected_by → fasting-mimicking diet (FMD)
affected_by → Mediterranean diet

macroalbuminuria

measurement · ID: macroalbuminuria

reduction_in_FMD: not observed
reduction_in_M-Diet: not observed

Relationships

not_affected_by → fasting-mimicking diet (FMD)

HOMA-IR

measurement · ID: homa_ir

improvement_in_FMD: sustained
improvement_in_M-Diet: not sustained

Relationships

affected_by → fasting-mimicking diet (FMD)

dicarbonyl detoxification markers

measurement · ID: dicarbonyl_detoxification_markers

MG-H1: transient reduction in FMD
suPAR: fast increase after FMD
Glo-1 activity: no change in WBC
pGlo-1 expression: no change in WBC
hydroxyacetone: no change in RBC

Relationships

lack_of_change_in → dicarbonyl detoxification markers

DNA-damage/repair markers

measurement · ID: dna_damage_repair_markers

change_in_FMD: no change
change_in_M-Diet: no change

Relationships

lack_of_change_in → DNA-damage/repair markers

glycemic control

concept · ID: glycemic_control

comparability: comparable between groups

Relationships

achieved_by → reduction in antihyperglycemic medication

blood pressure control

concept · ID: blood_pressure_control

comparability: comparable between groups

Relationships

achieved_by → reduction in antihypertensive medication

acylcarnitine profile

measurement · ID: acylcarnitine_profile

discriminatory_power: discriminated between responders and non-responders for ACR improvement

Relationships

associated_with → lipolysis activation during fasting

ketogenesis

other · ID: ketogenesis

role: orchestrates nephroprotective effects of SGLT-2 inhibitors by shifting energy metabolism to ketolysis
model_entity_type: biological_process

Relationships

related_to → fatty acid oxidation

glycine

concept · ID: glycine

role: protective effect on renal tubular injury

Relationships

associated_with → increase in responders

Source positions, MinHash and extraction warnings

{
  "source": {
    "chunk_index": 3,
    "start_word": 2958,
    "end_word": 3938,
    "word_count": 980,
    "sha256": "b12b4a0b1ffe140fe04f24bcf1429f31e74241bb588853abea05b6c6fe51e3de",
    "sentence_minhash": [
      14279474218976588,
      18551641988871988,
      12309405932600981,
      61919449716151556,
      31941388625203915,
      99436724310786061,
      23718652799488495,
      83575544965282909,
      96635883400075078,
      316267458192039586,
      19416574622547768,
      53801230756016856,
      38129318889309710,
      906306679132868,
      95169533629451962,
      109206766937244242
    ]
  },
  "extraction_warnings": [
    "normalized unsupported entity type 'biological_process' for 'ketogenesis'"
  ]
}

Previous KU: The study found that the fasting-mimicking diet reduced microalbuminuria and HOMA-IR, but not macroalbuminuria, with effects sustained only at the three-month follow-up. The researchers suggest that the lack of change in dicarbonyl detoxification and DNA-damage markers may explain the relapse of albuminuria.

Next KU: The study suggests that the transient nature of albuminuria reduction is due to a lack of sustained changes in dicarbonyl detoxification and DNA-damage repair markers, indicating that longer fasting-mimicking diet periods may be necessary for nephropathy reversal. The research highlights the clinical feasibility of integrating FMD into diabetes care, noting that the reduction in albuminuria was significant only in the subgroup of patients with microalbuminuria. The authors caution that the small sample size and the lack of renal biopsy data limit the generalizability and mechanistic understanding of the findings.

KU 5 · source words 3,939–4,701

9 entities · 13 relationships · 4 preceding KUs available during extraction

Recorded context summary

The study suggests that the transient nature of albuminuria reduction is due to a lack of sustained changes in dicarbonyl detoxification and DNA-damage repair markers, indicating that longer fasting-mimicking diet periods may be necessary for nephropathy reversal. The research highlights the clinical feasibility of integrating FMD into diabetes care, noting that the reduction in albuminuria was significant only in the subgroup of patients with microalbuminuria. The authors caution that the small sample size and the lack of renal biopsy data limit the generalizability and mechanistic understanding of the findings.

fasting-mimicking diet (FMD)

method · ID: fasting_mimicking_diet_fmd

duration: six-month periodic
mechanism_suggested: sustained redirection of metabolism
clinical_integration: well integrated with intensive diabetes care

Relationships

requires_longer_period_for → nephropathy reversal
reduces → microalbuminuria
improves → glycemic control
improves → blood pressure control
reduces → insulin resistance

Mediterranean diet

method · ID: mediterranean_diet

caloric_intake: isocaloric

Relationships

compared_to → fasting-mimicking diet (FMD)

microalbuminuria

measurement · ID: microalbuminuria

reduction_observed_in: subgroup analysis
baseline_status: predictor of diabetic nephropathy

Relationships

reduced_by → fasting-mimicking diet (FMD)

macroalbuminuria

measurement · ID: macroalbuminuria

reduction_observed: none

Relationships

not_reduced_by → fasting-mimicking diet (FMD)

dicarbonyl detoxification markers

measurement · ID: dicarbonyl_detoxification_markers

change_observed: none

Relationships

lack_of_change_suggests → relapse of albuminuria

DNA-damage/repair markers

measurement · ID: dna_damage_repair_markers

change_observed: none

Relationships

lack_of_change_suggests → relapse of albuminuria

renal cell metabolism

concept · ID: renal_cell_metabolism

study_limitation: not explored due to lack of kidney biopsies

Relationships

not_explored_in → this study

fasting-mimicking diet (FMD) subgroup analysis

method · ID: fasting_mimicking_diet_fmd_subgroup_analysis

focus: patients with microalbuminuria

Relationships

shows_significant_reduction_in → ACR

study limitations

concept · ID: study_limitations

sample_size: small
generalizability: limited

Relationships

requires_larger_cohorts_for → future studies

Source positions, MinHash and extraction warnings

{
  "source": {
    "chunk_index": 4,
    "start_word": 3938,
    "end_word": 4701,
    "word_count": 763,
    "sha256": "b66eb15556527f1d76e96d9703cb14bd56b4aa61742a03013ebd4efa05d7ef23",
    "sentence_minhash": [
      147519523736366927,
      1306423125707224,
      153262400589127199,
      37498130448765965,
      26384097017582652,
      99436724310786061,
      23718652799488495,
      47615437990415314,
      96635883400075078,
      17444917348060025,
      67831053780325945,
      95656761971753031,
      38129318889309710,
      906306679132868,
      196881419005778658,
      285412106277652386
    ]
  },
  "extraction_warnings": []
}

Previous KU: The study found that the fasting-mimicking diet reduced microalbuminuria and improved metabolic control in type 2 diabetes patients, but these effects were transient and did not alter macroalbuminuria. The diet led to a reduction in antihyperglycemic and antihypertensive medication use, and increased blood ketones, while maintaining comparable glycemic and blood pressure control to the Mediterranean diet group. The researchers attribute the transient nature of the albuminuria reduction to the lack of sustained changes in dicarbonyl detoxification and DNA-damage repair markers.

Next KU: End of paper